Viewing StudyNCT06475196



Ignite Creation Date: 2024-07-17 @ 11:24 AM
Last Modification Date: 2024-10-26 @ 3:33 PM
Study NCT ID: NCT06475196
Status: ENROLLING_BY_INVITATION
Last Update Posted: 2024-06-26
First Post: 2024-06-20

Brief Title: Prospective Cohort Study of Neoadjuvant Therapy With Sintilimab PD-1 Inhibitor Combined With Chemotherapy in Resectable ESCC
Sponsor: Tang-Du Hospital
Organization: Tang-Du Hospital

Conditions & Keywords Data

Conditions:
Name
Resectable Esophageal Squamous Cell Carcinoma
Keywords:
Name View
neoadjuvant therapy View
PD-1 inhibitor View
resectable esophageal squamous cell carcinoma View